China Anti-ulcer Drugs Market Report to 2021

November 2016 | 108 pages | ID: CF1D1E43218EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti-ulcer Drugs

Revenue, means the sales value of Anti-ulcer Drugs

This report studies sales (consumption) of Anti-ulcer Drugs in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group
• BAX
• Taishō Seiyaku Kabushiki-gaisha

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Histamine H2 Receptor Antagonist
• Proton Pump Inhibitor
• Others

Split by applications, this report focuses on sales, market share and growth rate of Anti-ulcer Drugs in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

China Anti-ulcer Drugs Market Report 2021

1 ANTI-ULCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Anti-ulcer Drugs
1.2 Classification of Anti-ulcer Drugs
  1.2.1 Histamine H2 Receptor Antagonist
  1.2.2 Proton Pump Inhibitor
  1.2.3 Others
1.3 Applications of Anti-ulcer Drugs
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 China Market Size (Value and Volume) of Anti-ulcer Drugs (2011-2021)
  1.4.1 China Anti-ulcer Drugs Sales, Revenue and Price (2011-2021)
  1.4.2 China Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
  1.4.3 China Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)

2 CHINA ANTI-ULCER DRUGS COMPETITION BY MANUFACTURERS

2.1 China Anti-ulcer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 China Anti-ulcer Drugs Revenue and Share by Manufactures (2015 and 2016)

3 CHINA ANTI-ULCER DRUGS (VOLUME AND VALUE) BY TYPE

3.1 China Anti-ulcer Drugs Sales and Market Share by Type (2011-2021)
3.2 China Anti-ulcer Drugs Revenue and Market Share by Type (2011-2021)

4 CHINA ANTI-ULCER DRUGS (VOLUME) BY APPLICATION

5 CHINA ANTI-ULCER DRUGS MANUFACTURERS ANALYSIS

5.1 Novartis
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Anti-ulcer Drugs Product Type and Technology
    5.1.2.1 Histamine H2 Receptor Antagonist
    5.1.2.2 Proton Pump Inhibitor
  5.1.3 Anti-ulcer Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
5.2 Pfizer, Inc.
  5.2.1 Company Basic Information,Manufacturing Base and Competitors
  5.2.2 Pharmaceuticals Product Type and Technology
    5.2.2.1 Histamine H2 Receptor Antagonist
    5.2.2.2 Proton Pump Inhibitor
  5.2.3 Pharmaceuticals Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
5.3 Roche
  5.3.1 Company Basic Information,Manufacturing Base and Competitors
  5.3.2 Roche Product Type and Technology
    5.3.2.1 Histamine H2 Receptor Antagonist
    5.3.2.2 Proton Pump Inhibitor
  5.3.3 Roche Sales, Revenue, Price of Roche (2015 and 2016)
5.4 Sanofi
  5.4.1 Company Basic Information,Manufacturing Base and Competitors
  5.4.2 Eli Lilly and Company Product Type and Technology
    5.4.2.1 Histamine H2 Receptor Antagonist
    5.4.2.2 Proton Pump Inhibitor
  5.4.3 Sanofi Sales, Revenue, Price of Sanofi (2015 and 2016)
5.5 Merck & Co., Inc.
  5.5.1 Company Basic Information,Manufacturing Base and Competitors
  5.5.2 Merck & Co., Inc. Product Type and Technology
    5.5.2.1 Histamine H2 Receptor Antagonist
    5.5.2.2 Proton Pump Inhibitor
  5.5.3 Merck & Co., Inc. Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
5.6 GlaxoSmithKline plc
  5.6.1 Company Basic Information,Manufacturing Base and Competitors
  5.6.2 GlaxoSmithKline plc Product Type and Technology
    5.6.2.1 Histamine H2 Receptor Antagonist
    5.6.2.2 Proton Pump Inhibitor
  5.6.3 GlaxoSmithKline plc Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
5.7 Johnson & Johnson
  5.7.1 Company Basic Information,Manufacturing Base and Competitors
  5.7.2 Johnson & Johnson Product Type and Technology
    5.7.2.1 Histamine H2 Receptor Antagonist
    5.7.2.2 Proton Pump Inhibitor
  5.7.3 Johnson & Johnson Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
5.8 AstraZeneca plc.
  5.8.1 Company Basic Information,Manufacturing Base and Competitors
  5.8.2 AstraZeneca plc. Product Type and Technology
    5.8.2.1 Histamine H2 Receptor Antagonist
    5.8.2.2 Proton Pump Inhibitor
  5.8.3 AstraZeneca plc. Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
5.9 Eli Lilly and Company
  5.9.1 Company Basic Information,Manufacturing Base and Competitors
  5.9.2 Eli Lilly and Company Product Type and Technology
    5.9.2.1 Histamine H2 Receptor Antagonist
    5.9.2.2 Proton Pump Inhibitor
  5.9.3 Eli Lilly and Company Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
5.10 Abbvie
  5.10.1 Company Basic Information,Manufacturing Base and Competitors
  5.10.2 Abbvie Product Type and Technology
    5.10.2.1 Histamine H2 Receptor Antagonist
    5.10.2.2 Proton Pump Inhibitor
  5.10.3 Abbvie Sales, Revenue, Price of Abbvie (2015 and 2016)
5.11 AMGen
5.12 Teva Pharmaceutical Industries Ltd.
5.13 Bayer AG
5.14 Bristol-Myers Squibb
5.15 Astellas Pharma
5.16 Daiichi Sankyo
5.17 Abbott Laboratories
5.18 Yangtze River Pharmaceutical Group
5.19 BAX
5.20 Taishō Seiyaku Kabushiki-gaisha

6 ANTI-ULCER DRUGS TECHNOLOGY AND DEVELOPMENT TREND

6.1 Anti-ulcer Drugs Technology Analysis
6.2 Anti-ulcer Drugs Technology Development Trend

7 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-ulcer Drugs
Table Classification of Anti-ulcer Drugs
Figure China Sales Market Share of Anti-ulcer Drugs by Type in 2015
Figure Histamine H2 Receptor Antagonist Picture
Figure Proton Pump Inhibitor Picture
Figure Others Picture
Table Applications of Anti-ulcer Drugs
Figure China Sales Market Share of Anti-ulcer Drugs by Application in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Table China Anti-ulcer Drugs Sales, Revenue and Price (2011-2021)
Figure China Anti-ulcer Drugs Sales and Growth Rate (2011-2021)
Figure China Anti-ulcer Drugs Revenue and Growth Rate (2011-2021)
Table China Anti-ulcer Drugs Sales of Key Manufacturers (2015 and 2016)
Table China Anti-ulcer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-ulcer Drugs Sales Share by Manufacturers
Figure 2016 Anti-ulcer Drugs Sales Share by Manufacturers
Table China Anti-ulcer Drugs Revenue by Manufacturers (2015 and 2016)
Table China Anti-ulcer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Anti-ulcer Drugs Revenue Share by Manufacturers
Table 2016 China Anti-ulcer Drugs Revenue Share by Manufacturers
Table China Anti-ulcer Drugs Sales and Market Share by Type (2011-2021)
Table China Anti-ulcer Drugs Sales Share by Type (2011-2021)
Figure Sales Market Share of Anti-ulcer Drugs by Type (2011-2021)
Figure China Anti-ulcer Drugs Sales Growth Rate by Type (2011-2021)
Table China Anti-ulcer Drugs Revenue and Market Share by Type (2011-2021)
Table China Anti-ulcer Drugs Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Anti-ulcer Drugs by Type (2011-2021)
Figure China Anti-ulcer Drugs Revenue Growth Rate by Type (2011-2021)
Table China Anti-ulcer Drugs Sales and Market Share by Application (2011-2021)
Table China Anti-ulcer Drugs Sales Share by Application (2011-2021)
Figure Sales Market Share of Anti-ulcer Drugs by Application (2011-2021)
Figure China Anti-ulcer Drugs Sales Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
Table Abbott Laboratories Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
Table Yangtze River Pharmaceutical Group Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
Table BAX Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of BAX (2015 and 2016)
Table Taishō Seiyaku Kabushiki-gaisha Basic Information List
Table Anti-ulcer Drugs Sales, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)